Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Bimatoprost 0.01% effectively and safely improves eyebrow growth.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

A hair restoration technique was introduced that mixes different types of hair groupings to reduce procedure time, limit damage, and potentially increase hair density, suggesting more hair can be transplanted than previously thought.

A family showed a new condition with inherited hair loss and skin changes, possibly due to one genetic disorder.

Topical bimatoprost 0.01% improves eyebrow density and diameter, especially at the tail.

Panitumumab can cause excessive ear hair growth.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

New drug shows promise for better hair growth in baldness treatment.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Zidovudine may cause hair loss in advanced-stage HIV patients.

Gray hair can potentially be reversed, leading to new treatments.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The baby’s hair loss was due to a rare genetic condition, not treatable by usual methods.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Genetic testing is crucial for diagnosing congenital atrichia, a rare condition causing irreversible hair loss.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

There are many treatments for common hair loss, but more trials are needed to decide which are best.